NO20043425L - Kondenserte bicykliske pyrimdin-derivater - Google Patents
Kondenserte bicykliske pyrimdin-derivaterInfo
- Publication number
- NO20043425L NO20043425L NO20043425A NO20043425A NO20043425L NO 20043425 L NO20043425 L NO 20043425L NO 20043425 A NO20043425 A NO 20043425A NO 20043425 A NO20043425 A NO 20043425A NO 20043425 L NO20043425 L NO 20043425L
- Authority
- NO
- Norway
- Prior art keywords
- pyrimdine
- derivatives
- ring
- condensed bicyclic
- receptor antagonist
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Otolaryngology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002009373 | 2002-01-18 | ||
| PCT/JP2003/000263 WO2003062245A1 (en) | 2002-01-18 | 2003-01-15 | Fused bicyclic pyrimidine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20043425L true NO20043425L (no) | 2004-08-17 |
Family
ID=27605963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20043425A NO20043425L (no) | 2002-01-18 | 2004-08-17 | Kondenserte bicykliske pyrimdin-derivater |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6995153B2 (no) |
| EP (1) | EP1473295B1 (no) |
| JP (1) | JP4417720B2 (no) |
| KR (1) | KR100887471B1 (no) |
| CN (1) | CN1297559C (no) |
| AT (1) | ATE427310T1 (no) |
| AU (1) | AU2003201885B2 (no) |
| BR (1) | BR0307156A (no) |
| CA (1) | CA2472835A1 (no) |
| DE (1) | DE60326933D1 (no) |
| MX (1) | MXPA04006571A (no) |
| NO (1) | NO20043425L (no) |
| NZ (1) | NZ533540A (no) |
| WO (1) | WO2003062245A1 (no) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005019225A1 (ja) * | 2003-08-21 | 2005-03-03 | Kyorin Pharmaceutical Co., Ltd. | Nk1受容体拮抗作用を有する化合物の製造方法及びその製造中間体 |
| AU2004283038B9 (en) * | 2003-10-27 | 2008-04-24 | Novartis Ag | Use of neurokinin antagonists in the treatment of urinary incontinence |
| JP5528699B2 (ja) | 2006-05-16 | 2014-06-25 | 武田薬品工業株式会社 | 縮合複素環化合物およびその用途 |
| US20090036425A1 (en) * | 2007-08-02 | 2009-02-05 | Pfizer Inc | Substituted bicyclolactam compounds |
| WO2013004766A1 (en) | 2011-07-04 | 2013-01-10 | Ferrari Giulio | Nk-1 receptor antagonists for treating corneal neovascularisation |
| FR2986232B1 (fr) * | 2012-01-26 | 2014-02-14 | Sanofi Sa | Derives heterocycliques bicycliques, leur preparation et leur application en therapeutique |
| CA3078945A1 (en) * | 2017-10-09 | 2019-04-18 | Nuvation Bo Inc. | Heterocyclic compounds and uses thereof |
| EP3694861A4 (en) | 2017-10-09 | 2021-05-19 | Nuvation Bio Inc. | HETEROCYCLIC COMPOUNDS AND USES THEREOF |
| RU2020131446A (ru) | 2018-02-26 | 2022-03-28 | Оспедале Сан Раффаэле С.Р.Л. | Антагонисты nk-1 для применения в лечении глазной боли |
| JP2022526831A (ja) | 2019-04-09 | 2022-05-26 | ニューベイション・バイオ・インコーポレイテッド | ヘテロ環式化合物およびその使用 |
| EP3952878A4 (en) * | 2019-04-09 | 2023-01-04 | Nuvation Bio Inc. | HETEROCYCLIC COMPOUNDS AND THEIR USES |
| EP3952879A4 (en) * | 2019-04-09 | 2023-01-04 | Nuvation Bio Inc. | HETEROCYCLIC COMPOUNDS AND THEIR USES |
| EP4117673A1 (en) | 2020-03-11 | 2023-01-18 | Ospedale San Raffaele S.r.l. | Treatment of stem cell deficiency |
| WO2026154417A1 (en) * | 2025-01-17 | 2026-07-23 | Pfizer Inc. | Fused heterocyclic amide/sulfonamide compounds as agonists of the calcitonin/amylin receptors for the treatment of obesity |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW263498B (no) | 1993-11-10 | 1995-11-21 | Takeda Pharm Industry Co Ltd | |
| EP0733632B1 (en) | 1995-03-24 | 2003-06-04 | Takeda Chemical Industries, Ltd. | Cyclic compounds, their production and use as tachykinin receptor antagonists |
| TW382017B (en) * | 1995-12-27 | 2000-02-11 | Janssen Pharmaceutica Nv | 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives |
-
2003
- 2003-01-15 KR KR1020047011126A patent/KR100887471B1/ko not_active Expired - Fee Related
- 2003-01-15 BR BR0307156-1A patent/BR0307156A/pt not_active IP Right Cessation
- 2003-01-15 DE DE60326933T patent/DE60326933D1/de not_active Expired - Lifetime
- 2003-01-15 US US10/501,551 patent/US6995153B2/en not_active Expired - Fee Related
- 2003-01-15 CA CA002472835A patent/CA2472835A1/en not_active Abandoned
- 2003-01-15 MX MXPA04006571A patent/MXPA04006571A/es active IP Right Grant
- 2003-01-15 CN CNB03802425XA patent/CN1297559C/zh not_active Expired - Fee Related
- 2003-01-15 AU AU2003201885A patent/AU2003201885B2/en not_active Ceased
- 2003-01-15 WO PCT/JP2003/000263 patent/WO2003062245A1/ja not_active Ceased
- 2003-01-15 JP JP2003562122A patent/JP4417720B2/ja not_active Expired - Fee Related
- 2003-01-15 EP EP03700567A patent/EP1473295B1/en not_active Expired - Lifetime
- 2003-01-15 AT AT03700567T patent/ATE427310T1/de not_active IP Right Cessation
- 2003-01-15 NZ NZ533540A patent/NZ533540A/en not_active IP Right Cessation
-
2004
- 2004-08-17 NO NO20043425A patent/NO20043425L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003201885B2 (en) | 2007-08-30 |
| CA2472835A1 (en) | 2003-07-31 |
| JPWO2003062245A1 (ja) | 2005-05-19 |
| KR20040072732A (ko) | 2004-08-18 |
| KR100887471B1 (ko) | 2009-03-10 |
| EP1473295A1 (en) | 2004-11-03 |
| BR0307156A (pt) | 2004-12-07 |
| EP1473295A4 (en) | 2005-12-28 |
| ATE427310T1 (de) | 2009-04-15 |
| NZ533540A (en) | 2006-04-28 |
| JP4417720B2 (ja) | 2010-02-17 |
| MXPA04006571A (es) | 2004-10-04 |
| DE60326933D1 (de) | 2009-05-14 |
| CN1297559C (zh) | 2007-01-31 |
| WO2003062245A1 (en) | 2003-07-31 |
| US6995153B2 (en) | 2006-02-07 |
| US20050085469A1 (en) | 2005-04-21 |
| EP1473295B1 (en) | 2009-04-01 |
| CN1620459A (zh) | 2005-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0414592A (pt) | antagonistas de receptores de trombina | |
| EA200500342A1 (ru) | Гетероциклические замещённые пиперазины для лечения шизофрении | |
| EA200300829A1 (ru) | Производные 1-арил- или 1-алкилсульфонилбензазола в качестве лигандов 5-гидрокситриптамина-6 | |
| ATE427310T1 (de) | Kondensierte bicyclische pyrimidinderivate | |
| ATE377589T1 (de) | 6-substituierte nikotinamidderivate als opioidrezeptorantagonisten | |
| ATE429427T1 (de) | Pyrimidinderivate als orexin-rezeptorantagonisten | |
| EA200300595A1 (ru) | Соединения пиперазинилпиразинов в качестве антагонистов серотонин 5-ht2 рецептора | |
| ATE377602T1 (de) | Morphinanderivate und ihre medizinische anwendung | |
| MXPA05013474A (es) | Derivados de quinolilamida como antagonistas de ccr-5. | |
| BR0206595A (pt) | Composto, composição farmacêutica, e uso de um composto | |
| DK1129091T3 (da) | Antagonister for CRF-receptorer og fremgangsmåder med relation dertil | |
| PT1129096E (pt) | Antagonistas de receptor de crf e metodos de tratamento relacionados com os mesmos | |
| EA200401455A1 (ru) | Производные бензоксазина в качестве модуляторов 5-htи их применение | |
| EA200300629A1 (ru) | Конденсированные производные пурина как антагонисты рецепторов аденозина a | |
| EA200600688A1 (ru) | Арилинденпиридины и арилинденпиримидины и их применение в качестве антагонистов аденозинового рецептора а2а | |
| FR2801585B1 (fr) | Nouveaux antagonistes des recepteurs de l'ii-8 | |
| DE60315626D1 (de) | Kondensierte bicyclische pyrimidinderivate | |
| CY1108837T1 (el) | ΝΕΑ ΠΑΡΑΓΩΓΑ ΑΜΙΝΟΠΥΡΙΔΙΝΗΣ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ mGluR5 | |
| ATE407133T1 (de) | 2-imidazo-benzothiazole als adenosin-rezeptor liganden | |
| EA200400822A1 (ru) | Производные 3,4-дигидро-1h-изохинолин-2-ила | |
| TR200001080T2 (tr) | 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri | |
| ATE260918T1 (de) | Crf rezeptor-antagonisten und darauf bezogene methoden | |
| EA200300226A1 (ru) | ГЕМ-ЗАМЕЩЕННЫЕ АНТАГОНИСТЫ ИНТЕГРИНА αvβ3 | |
| EP1489083A4 (en) | CONDENSED, BICYCLIC PYRIDINE DERIVATIVES AS ANTAGONISTS OF THE TACHYKININ RECEPTOR | |
| EP1457493A4 (en) | CONDENSED, BICYCLIC PYRIDINE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |